Curcumin and 5-Fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: A synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 437-459

  Balasubramanian, Sivakumar ^a   Ravindran Girija, Aswathy ^a   Nagaoka, Yutaka ^a   Iwai, Seiki ^a   Suzuki, Masashi ^a   Kizhikkilot, Venugopal ^b   Yoshida, Yasuhiko ^a   Maekawa, Toru ^a   Dasappan Nair, Sakthikumar ^a  

^a TOYO UNIVERSITY   (Japan)

^b Sooriya Hospital   (India)

Author keywords

5FU; Curcumin; Folate; Magnetic hyperthermia; Nanotechnology; PLGA nanoparticle; Transferrin

Indexed keywords

CURCUMIN; FLUOROURACIL; FOLIC ACID; MAGNETIC NANOPARTICLE; POLYGLACTIN; TRANSFERRIN; ANTINEOPLASTIC AGENT; DRUG CARRIER; LACTIC ACID; MAGNETITE NANOPARTICLE; NANOCONJUGATE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL DESTRUCTION; CONTROLLED STUDY; CYTOSKELETON; DRUG CONJUGATION; DRUG FORMULATION; DRUG MIXTURE; DRUG POTENTIATION; GLIA CELL; HUMAN; HUMAN CELL; HYPERTHERMIA; MAGNETIC FIELD; MAGNETIC HYPERTHERMIA; MITOCHONDRIAL MEMBRANE POTENTIAL; NANOPHARMACEUTICS; REACTION TIME; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; HYPERTHERMIC THERAPY; MCF 7 CELL LINE; MOUSE; MULTIMODALITY CANCER THERAPY; NANOMEDICINE; NANOTECHNOLOGY; NEOPLASMS; PATHOLOGY; PROCEDURES;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE; COMBINED MODALITY THERAPY; CURCUMIN; DRUG CARRIERS; FLUOROURACIL; FOLIC ACID; HUMANS; HYPERTHERMIA, INDUCED; LACTIC ACID; MAGNETITE NANOPARTICLES; MCF-7 CELLS; MICE; NANOCONJUGATES; NANOMEDICINE; NANOTECHNOLOGY; NEOPLASMS; POLYGLYCOLIC ACID; TRANSFERRIN;

EID: 84892389851     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S49882     Document Type: Article

References (69)

1. Baselt DR, Lee GU, Hansen KM, Chrisey LA, Colton RJ. A high-sensitivity micromachined biosensor. Proc IEEE Inst Electr Electron Eng. 1997;85(4):672-680.
2. Safarík I, Safaríková M. Use of magnetic techniques for the isolation of cells. J Chromatogr B Biomed Sci Appl. 1999;722(1-2):33-53.
3. Halbreich A, Roger J, Pons JN, etal. Biomedical applications of maghemite ferrofluid. Biochimie. 1999;80(5-6):379-390.
4. Fortin JP, Wilhelm C, Servais J, Ménager C, Bacri JC, Gazeau F. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J Am Chem Soc. 2007;129(9):2628-2635.
5. Hergt R, Hiergeist R, Hilger I, etal. Maghemite nanoparticles with very high AC-losses for application in RF-magnetic hyperthermia. J Magn Magn Mater. 2004;270(3):345-357.
6. Chemla YR, Grossman HL, Poon Y, etal. Ultrasensitive magnetic biosensor for homogeneous immunoassay. Proc Natl Acad Sci U S A. 2000;97(26):14268-14272.
7. Briley-Saebo K, Bjørnerud A, Grant D, Ahlstrom H, Berg T, Kindberg GM. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging. Cell Tissue Res. 2004;316(3):315-323.
8. Stark DD, Weissleder R, Elizondo G, etal. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology. 1988;168(2):297-301.
9. Häfeli UO. Magnetically modulated therapeutic systems. Int J Pharm. 2004;277(1-2):19-24.
10. Mahmoudi M, Simchi A, Imani M, etal. A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloids Surf B Biointerfaces. 2010;75(1):300-309.
11. Ito A, Takizawa Y, Honda H, etal. Tissue engineering using magnetite nanoparticles and magnetic force: heterotypic layers of cocultured hepatocytes and endothelial cells. Tissue Eng. 2004;10(5-6):833-840.
12. Alexiou C, Schmidt A, Klein R, Hulin P, Bergemann C, Arnold W. Magnetic drug targeting: biodistribution and dependency on magnetic field strength. J Magn Magn Mater. 2002;252:363-366.
13. Pan Y, Du X, Zhao F, Xu B. Magnetic nanoparticles for the manipulation of proteins and cells. Chem Soc Rev. 2012;41(7):2912-2942.
14. Xu C, Sun S. Superparamagnetic nanoparticles as targeted probes for diagnostic and therapeutic applications. Dalton Trans. 2009;(29): 5583-5591.
15. Perez CA, Emami B, Myerson RJ. Hyperthermia: In Principle and Practice of Radiation Oncology. Philadelphia, PA: Lippincott; 1992.
16. Maier-Hauff K, Rothe R, Scholz R, etal. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol. 2007;81(1):53-60.
17. Berry CC, Curtis ASG. Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys. 2003;36: R198-R206.
18. Gordon RT, Hines JR, Gordon D. Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. Med Hypotheses. 1979;5(1):83-102.
19. Hilger I, Andrä W, Hergt R, Hiergeist R, Schubert H, Kaiser WA. Electromagnetic heating of breast tumors in interventional radiology: in vitro and in vivo studies in human cadavers and mice. Radiology. 2001;218(2):570-575.
20. Dormer K, Seeney C, Lewelling K, Lian G, Gibson D, Johnson M. Epithelial internalization of superparamagnetic nanoparticles and response to external magnetic field. Biomaterials. 2005;26(14):2061-2072.
21. Murray TG, Steeves RA, Gentry L, etal. Ferromagnetic hyperthermia: functional and histopathologic effects on normal rabbit ocular tissue. Int J Hyperthermia. 1997;13(4):423-436.
22. Jordan A, Scholz R, Wust P, etal. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. Int J Hyperthermia. 1997;13(6):587-605.
23. O'Brien KT, Mekkaoui AM. Numerical simulation of the thermal fields occurring in the treatment of malignant tumors by local hyperthermia. J Biomech Eng. 1993;115(3):247-253.
24. Chen JS, Poirier DR, Damento MA, Demer LJ, Biancaniello F, Cetas TC. Development of Ni-4 wt% Si thermoseeds for hyperthermia cancer treatment. J Biomed Mater Res. 1988;22(4):303-319.
25. Brezovich IA. Low frequency hypothermia: capacitive and ferromagnetic thermoseed methods. In: Palival PR, Hetzel FW, editors. Medical Physics Monograph. New York, NY: American Institute of Physics; 1988:82-111.
26. Cullity BD. Introduction to Magnetic Materials. Reading, MA: Addison-Wesley; 1972.
27. Esmaeili F, Ghahremani MH, Esmaeili B, Khoshayand MR, Atyabi F, Dinarvand R. PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. Int J Pharm. 2008;349(1-2):249-255.
28. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28(1):5-24.
29. Singh A, Dilnawaz F, Mewar S, Sharma U, Jagannathan NR, Sahoo SK. Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. ACS Appl Mater Interfaces. 2011;3(3):842-856.
30. Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL. A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res. 2005;2(2):131-136.
31. Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 2009;11(3):495-510.
32. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23(1A): 363-398.
33. Cartiera MS, Ferreira EC, Caputo C, Egan ME, Caplan MJ, Saltzman WM. Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin. Mol Pharm. 2010;7(1):86-93.
34. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol. 2008;75(4):787-809.
35. Corson TW, Crews CM. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell. 2007;130(5):769-774.
36. Golombick T, Diamond TH, Badmaev V, Manoharan A, Ramakrishna R. The potential role of curcumin in patients with monoclonal gammopathy of undefined significance-its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker. Clin Cancer Res. 2009;15(18):5917-5922.
37. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269(2):199-225.
38. Tharakan ST, Inamoto T, Sung B, Aggarwal BB, Kamat AM. Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. Biochem Pharmacol. 2010; 79(2):218-228.
39. Kuttan R, Sudheeran PC, Josph CD. Turmeric and curcumin as topical agents in cancer therapy. Tumori. 1987;73(1):29-31.
40. Cho YW, Lee JR, Song SC. Novel thermosensitive 5-fluorouracil-cyclotriphosphazene conjugates: synthesis, thermosensitivity, degradability, and in vitro antitumor activity. Bioconjug Chem. 2005;16(6):1529-1535.
41. Chen AZ, Pu XM, Kang YQ, Liao L, Yao YD, Yin GF. Preparation of 5-fluorouracil-poly(L-lactide) microparticles using solution-enhanced dispersion by supercritical CO2. Macromol Rapid Commun. 2006;27(15):1254-1259.
42. Hong H, Yang K, Zhang Y, etal. In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. ACS Nano. 2012;6(3):2361-2370.
43. Sasidharan A, Chandran P, Menon D, Raman S, Nair S, Koyakutty M. Rapid dissolution of ZnO nanocrystals in acidic cancer microenvironment leading to preferential apoptosis. Nanoscale. 2011;3(9): 3657-3669.
44. Moghimi SM, Peer D, Langer R. Reshaping the future of nanopharmaceuticals: ad iudicium. ACS Nano. 2011;5(11):8454-8458.
45. Xiao Z, Levy-Nissenbaum E, Alexis F, etal. Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. ACS Nano. 2012;6(1):696-704.
46. Perfézou M, Turner A, Merkoçi A. Cancer detection using nanoparticle-based sensors. Chem Soc Rev. 2012;41(7):2606-2622.
47. Mulik RS, Mönkkönen J, Juvonen RO, Mahadik KR, Paradkar AR. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm. 2010;398(1-2):190-203.
48. Sahoo SK, Ma W, Labhasetwar V. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int J Cancer. 2004;112(2):335-340.
49. Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials. 2010;31(25):6597-6611.
50. Pan J, Feng SS. Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers. Biomaterials. 2009;30(6):1176-1183.
51. Mohapatra S, Pal D, Ghosh SK, Pramanik P. Design of superparamagnetic iron oxide nanoparticle for purification of recombinant proteins. J Nanosci Nanotechnol. 2007;7(9):3193-3199.
52. Sivakumar B, Aswathy RG, Nagaoka Y, etal. Multifunctional carboxymethyl cellulose-based magnetic nanovector as a theragnostic system for folate receptor targeted chemotherapy, imaging, and hyperthermia against cancer. Langmuir. 2013;29(10):3453-3466.
53. Dilnawaz F, Singh A, Sahoo SK. Transferrin-conjugated curcumin-loaded superparamagnetic iron oxide nanoparticles induce augmented cellular uptake and apoptosis in K562 cells. Acta Biomater. 2012;8(2):704-719.
54. Kim DH, Lee SH, Im KH, etal. Surface-modified magnetite nanoparticles for hyperthermia: preparation, characterization, and cytotoxic studies. Curr Appl Phys. 2006;6(Suppl 1):e242-e246.
55. Gonçalves C, Pereira P, Gama M. Self-assembled hydrogel nanoparticles for drug delivery applications. Materials (Basel). 2010;3(2):1420-1460.
56. Avellino R, Romano S, Parasole R, etal. Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells. Blood. 2005;106(4):1400-1406.
57. Zamzami N, Susin SA, Marchetti P, etal. Mitochondrial control of nuclear apoptosis. J Exp Med. 1996;183(4):1533-1544.
58. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun. 1993;197(1):40-45.
59. Bernardi P, Petronilli V. The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J Bioenerg Biomembr. 1996;28(2):131-138.
60. Zoratti M, Szabó I. Electrophysiology of the inner mitochondrial membrane. J Bioenerg Biomembr. 1994;26(5):543-553.
61. Mashima T, Naito M, Noguchi K, Miller DK, Nicholson DW, Tsuruo T. Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene. 1997;14(9):1007-1012.
62. Luchetti F, Mannello F, Canonico B, etal. Integrin and cytoskeleton behaviour in human neuroblastoma cells during hyperthermia-related apoptosis. Apoptosis. 2004;9(5):635-648.
63. Willingham MC. Cytochemical methods for the detection of apoptosis. J Histochem Cytochem. 1999;47(9):1101-1110.
64. Borrelli MJ, Wong RS, Dewey WC. A direct correlation between hyperthermia-induced membrane blebbing and survival in synchronous G1 CHO cells. J Cell Physiol. 1986;126(2):181-190.
65. Prasad NK, Rathinasamy K, Panda D, Bahadur D. Mechanism of cell death induced by magnetic hyperthermia with nanoparticles of γ-MnxFe2-xO3synthesized by a single step process. J Mater Chem. 2007;17(48):5042-5051.
66. Rodríguez-Luccioni HL, Latorre-Esteves M, Méndez-Vega J, etal. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles. Int J Nanomedicine. 2011;6:373-380.
67. Asín L, Ibarra MR, Tres A, Goya GF. Controlled cell death by magnetic hyperthermia: effects of exposure time, field amplitude, and nanoparticle concentration. Pharm Res. 2012;29(5):1319-1327.
68. Hwang SY, Cho SH, Lee BH, Song YJ, Lee EK. Cellular imaging assay for early evaluation of an apoptosis inducer. Apoptosis. 2011;16(10): 1068-1075.
69. Garcia MP, Cavalheiro JR, Fernandes MH. Acute and long-term effects of hyperthermia in B16-F10melanoma cells. PLoS One. 2012;7(4): e35489.